MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 18 filers reported holding MYRIAD GENETICS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $262,000 | -99.5% | 7,249 | -99.6% | 0.00% | -99.6% |
| Q2 2017 | $47,772,000 | +32.2% | 1,848,772 | -1.7% | 0.46% | +35.6% |
| Q1 2017 | $36,128,000 | +15.0% | 1,881,650 | -0.2% | 0.34% | +19.7% |
| Q4 2016 | $31,425,000 | -27.0% | 1,885,123 | -9.9% | 0.28% | -28.5% |
| Q3 2016 | $43,036,000 | -7.7% | 2,091,137 | +37.2% | 0.40% | -6.8% |
| Q2 2016 | $46,627,000 | -13.1% | 1,523,758 | +6.3% | 0.43% | -12.7% |
| Q1 2016 | $53,650,000 | -19.4% | 1,433,338 | -7.1% | 0.49% | -17.3% |
| Q4 2015 | $66,566,000 | -3.8% | 1,542,315 | -16.4% | 0.59% | -4.8% |
| Q3 2015 | $69,174,000 | +4.0% | 1,845,622 | -5.7% | 0.62% | +3.3% |
| Q2 2015 | $66,493,000 | +12.0% | 1,956,266 | +16.6% | 0.60% | +13.0% |
| Q1 2015 | $59,381,000 | -2.7% | 1,677,423 | -6.4% | 0.53% | -0.2% |
| Q4 2014 | $61,057,000 | +119.2% | 1,792,621 | +148.2% | 0.53% | +57.4% |
| Q3 2014 | $27,858,000 | -60.4% | 722,272 | -60.1% | 0.34% | -44.3% |
| Q2 2014 | $70,387,000 | -3.8% | 1,808,510 | -15.5% | 0.61% | -2.7% |
| Q1 2014 | $73,182,000 | +33.0% | 2,140,444 | -18.4% | 0.62% | +23.8% |
| Q4 2013 | $55,025,000 | -2.0% | 2,622,732 | +9.8% | 0.50% | -23.5% |
| Q3 2013 | $56,144,000 | -1.1% | 2,389,114 | +13.1% | 0.66% | -5.6% |
| Q2 2013 | $56,759,000 | +29.5% | 2,112,359 | +22.5% | 0.70% | +28.1% |
| Q1 2013 | $43,825,000 | – | 1,724,726 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |